Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/1999
06/09/1999EP0920310A1 Use of aminothiolester derivatives in pharmaceutics
06/09/1999EP0920307A2 Derivates from bisaryltetracarbonacid, and pharmarceutical product containing them
06/09/1999EP0920301A1 Therapeutic or hygienic compositions with controlled and prolonged release of the active principle(s), in particular for ophthalmic use
06/09/1999EP0808157B1 Medicated tissue paper product
06/09/1999EP0713390B1 Gelatin capsules containing a highly concentrated acetaminophen solution
06/09/1999EP0578723B1 PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS
06/09/1999CN1219168A Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors
06/09/1999CN1219131A Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors
06/09/1999CN1219104A Method of treating renomous bites and stings
06/09/1999CN1218692A Novel Anti-spasmodic composition and process for manufacture thereof
06/09/1999CA2218199A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof
06/08/1999US5910510 Administering a photoactive absorber, e.g. a porphyrin, and waiting to have it localize in ocular tissue; radiating with laser light; macular degeneration; treating neovascularization
06/08/1999US5910489 Treating skin diseases such as cancer, liver spots, genital warts, by topically applying a penetrating formulation of hyaluronic acid and/or salts and an agent to treat the skin such as a nonsteroidal antiinflammatory drug
06/08/1999US5910485 Lower toxicity and high effectiveness through mixture with doxorubicin (adriamycin)
06/08/1999US5910482 Effective treating pregnancy disorder and premature labor in a pregnant female mammal
06/08/1999US5910451 Trophinin and trophinin-assisting proteins
06/08/1999US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50)
06/08/1999US5910414 Diagnosing bacterial infection by screening infected tissue using probes to identify nucleic acid sequences og bacterial enzyme
06/08/1999US5910322 Delayed release pharmaceutical formulation containing amoxycillin and potassium clavulanate
06/08/1999US5909734 Treatment and prevention of bacterial pneumonia; pulmonary aerosolization
06/08/1999CA2242308A1 Novel compounds
06/03/1999WO1999027129A1 Virulence-associated nucleic acid sequences and uses thereof
06/03/1999WO1999027127A1 NOVEL ribB
06/03/1999WO1999027126A1 ribG
06/03/1999WO1999027125A1 ribA
06/03/1999WO1999027104A1 Histamine and serotonin binding molecules
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027095A1 Human cdc10 homolog
06/03/1999WO1999026959A1 NOVEL recJ
06/03/1999WO1999026661A1 A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia
06/03/1999WO1999026660A2 Conjugates of cytokines and drugs or genes for treating proliferating cells
06/03/1999WO1999026659A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
06/03/1999WO1999026655A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999WO1999026651A1 ribH
06/03/1999WO1999026645A1 Method of mobilizing hematopoietic stem cells
06/03/1999WO1999026633A1 Citicoline to treat motor neuron diseases and demyelinating diseases
06/03/1999WO1999026630A1 Testosterone inhibitors and use for the protection of neurons
06/03/1999WO1999026620A1 Choline esters of fatty acids and their use in the treatment of stroke
06/03/1999WO1999026609A2 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
06/03/1999WO1999026606A2 SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS
06/03/1999WO1999026583A2 Inhibtion of lipoprotein oxidation
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999013913A3 High viscosity liquid controlled delivery system as a device
06/03/1999WO1999013871A3 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
06/03/1999WO1999012965A3 April- a novel protein with growth effects
06/03/1999CA2311809A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999CA2311736A1 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
06/03/1999CA2311733A1 Proliferatively active product for treating proliferating cells
06/03/1999CA2311498A1 Choline esters of fatty acids and their use in the treatment of stroke
06/03/1999CA2311422A1 Citicoline to treat motor neuron diseases and demyelinating diseases
06/03/1999CA2311235A1 Method of mobilizing hematopoietic stem cells
06/03/1999CA2310561A1 Virulence-associated nucleic acid sequences and uses thereof
06/03/1999CA2310540A1 Human cdc10 homolog
06/03/1999CA2310069A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
06/03/1999CA2309855A1 Testosterone inhibitors and use for the protection of neurons
06/03/1999CA2309809A1 Histamine and serotonin binding molecules
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2303864A1 Inhibition of lipoprotein oxidation
06/03/1999CA2255318A1 Combination therapy
06/02/1999EP0919622A2 Surface expression of enzyme in gene directed prodrug therapy
06/02/1999EP0919245A2 NK-1 receptor antagonist and a systemic antiinflammatory corticosteroid for the treatment of emesis
06/02/1999EP0919236A1 Use of a norepinephrine uptake inhibitor for the treatment of oppositional defiant disorder
06/02/1999EP0919235A1 Use of a norepinephrine reuptake inhibitor for the treatment of conduct disorder
06/02/1999EP0919234A2 Potentiation of pharmaceuticals by moxonidine
06/02/1999EP0919232A1 Composition for use in the treatment and prevention of hyperuricemia
06/02/1999EP0918860A2 Tumor necrosis factor-related polypeptide
06/02/1999EP0918859A1 Testis-specific insulin homolog polypeptides
06/02/1999EP0918856A2 Two human nsp-like proteins
06/02/1999EP0918545A2 Tumour therapy
06/02/1999EP0918542A2 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes
06/02/1999EP0918540A1 Intradermal bovine polynucleotide vaccine
06/02/1999EP0918536A1 Composition comprising insulin and insulin-like growth factor-i (igf-i)
06/02/1999EP0918532A1 A novel method of detecting and treating cancer
06/02/1999EP0918528A1 Method for treating gastrointestinal damage
06/02/1999EP0918526A1 Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
06/02/1999EP0918519A1 Therapeutic treatment for vegf related occular diseases
06/02/1999EP0918515A2 USE OF INHIBITORS OF THE CELLULAR Na?+ /H?+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS
06/02/1999EP0918507A1 Aerosol formulations
06/02/1999EP0918458A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
06/02/1999EP0918455A1 Galanin
06/02/1999CN1218409A Stimulation of host defence mechanisms against viral challenges
06/02/1999CN1218405A Treatment of cystic disease with TNF-'alpha'
06/02/1999CN1218403A Formulation for use in prevention of pathogen induced diseases including HIV and HSV
06/02/1999CN1218402A Improvement of implantation rates after vitro fertilization
06/02/1999CN1218368A Method for treating common cold or allergic rhinitis
06/02/1999CA2254949A1 Transgenic animal
06/02/1999CA2223075A1 Drug binding protein
06/01/1999US5908923 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
06/01/1999US5908853 Therapy for sexual disorders
06/01/1999US5908848 Analgesics
06/01/1999US5908847 The new combination confers a synergistic effect, and provides unexpected efficacy
06/01/1999US5908835 Anti-tumor compositions containing taxane derivatives
06/01/1999US5908825 Dosage composition for nasal delivery and method of use of the same
06/01/1999US5908824 Dispersed homogeneously in and adsorbed homogeneously onto a mucosa protecting and/or tissue repairing agent
06/01/1999US5908639 Inhalation powder containing antistatic agent
06/01/1999US5908636 Polyalkylene glycol having an average molecular weight of about 400 to about 20,000
06/01/1999US5908628 Compositions with analgesic, antipyretic and antiinflammatory properties
06/01/1999CA2255325A1 Aldehyde oxidase inhibitors for treatment of aids
05/1999
05/27/1999WO1999025863A1 Transfection and transfer of male germ cells for generation of transgenic species
1 ... 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 ... 1151